DOCN Earnings

DOCN reported its earnings on 2026-02-24, showcasing a revenue of 242.39M against an estimate of 237.66M, resulting in a 1.99% surprise. The EPS was 0.44, surpassing the expected 0.38 by 15.79%. The stock experienced a 5.91% price change on the earnings day and a -5.37% change over the next five days, reflecting market reactions to the results.

Following DOCN's earnings announcement on 2026-02-24, the stock price moved by 5.91% on the day of the release. Over the subsequent five days, it saw a -5.37% change. Historically, DOCN's stock price tends to shift by an average of 0.81% in the 10 days leading up to earnings and 3.98% in the 10 days following, providing insight into potential market.

For 2026/Q1, analysts estimate DOCN's annual revenue to reach 248.27M, while the EPS is projected at 0.45. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between DOCN's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were unchanged by 0%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, DOCN's stock price typically moves by 0.81% in the 10 days before its earnings and 3.98% in the 10 days after. For the upcoming 2026/Q1 earnings, analysts expect an EPS of 0.45 and revenue of 248.27M.

The earnings call summary and Q&A indicate strong revenue growth, robust demand from AI-native customers, and innovative product development. Despite near-term margin compression due to capacity expansion, the company projects strong EBITDA and cash flow margins. The leasing model for GPUs ensures immediate cash generation, and the company's strategic focus on open-source models enhances competitiveness. The raised revenue guidance and commitment to capacity investments further support a positive outlook. Given the market cap, this should lead to a stock price increase of 2% to 8% over the next two weeks.